- N Engl J Med 2022; 387:388-390
Health systems and clinicians planning for a post-Roe America can look to Texas, which has already witnessed the impact of strict abortion bans on the provision of evidence-based, essential health care.
- N Engl J Med 2022; 387:367-368
The editors strongly condemn the U.S. Supreme Court’s decision to abolish longstanding legal protections by reversing Roe v. Wade.
- N Engl J Med 2022; 387:294-297
With policymakers targeting members of sexual and gender minority groups, the health care sector can mitigate resulting harm and advocate for evidence-based policies protecting health and well-being.
Physicians Spreading Misinformation on Social Media — Do Right and Wrong Answers Still Exist in Medicine?N Engl J Med 2022; 387:1-3
In light of widespread falsehoods about Covid-19 and its treatment and prevention, the American Board of Internal Medicine has informed doctors that disseminating misinformation is grounds for disciplinary sanctions.
- N Engl J Med 2022; 386:2161-2164
State efforts to prohibit gender-affirming care place physicians’ duties to avoid discrimination, protect privacy, meet standards of care, fulfill reporting requirements, and avoid committing crimes in direct conflict with one another.
Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. WadeN Engl J Med 2022; 386:2061-2064
With the overturn of Roe v. Wade appearing imminent, U.S. medical centers must prepare carefully to manage the systemwide impact of abortion’s criminalization.
- N Engl J Med 2022; 386:1969-1971
A case that would otherwise have set off an avalanche of investigations and therapeutics, family meetings, and consultations was quietly referred for charity hospice care, though Ms. M.’s immigration status made acceptance even by a hospice agency precarious.
- N Engl J Med 2022; 386:1955-1956
Firearm-related injury is now the leading cause of death among children and teens. We continue to fail to protect our youth from a preventable cause of death.
- N Engl J Med 2022; 386:1773-1775
The Biden administration has made important incremental progress in expanding access to affordable health insurance. But its struggles to enact a broader reform agenda reflect the daunting political constraints that limit U.S. health policy.
- N Engl J Med 2021; 385:1057-1059
Facing daunting political, legal, and fiscal challenges, the public option health plans recently enacted by Washington State, Nevada, and Colorado have been narrowed to such an extent that they may fail to meet their affordability and coverage goals.
- N Engl J Med 2021; 385:1060-1062
Public Option 2.0 may be the most realistic way to guarantee universal coverage with a broad choice of providers and with medical prices held down by the government. If the United States is to achieve this elusive goal, however, advocates need to lay the groundwork now.
- N Engl J Med 2021; 385:673-675
In June, the U.S. Supreme Court rejected what will probably be the last major case seeking to uproot the ACA. The Court’s decision most likely marks an end to Republicans’ efforts to achieve in the courts what they have been unable to achieve in Congress.
- N Engl J Med 2021; 385:675-677
Models that hold organizations responsible for managing patients’ total cost of care are an important tool for payment reform. Bringing more clinicians into such models is essential, and strengthening current participation incentives could generate long-term benefits.
- N Engl J Med 2021; 384:2361-2364
President Biden has made reforms intended to “protect and strengthen Medicaid” a centerpiece of his health policy agenda. Given Medicaid’s size and complexity, the administration faces myriad policy and operational challenges.
- N Engl J Med 2021; 384:489-491
A federal “Transparency in Coverage” rule requires insurers to disclose list prices and historical net prices for medications and to give patients personalized cost-sharing estimates. Despite industry opposition, the rule may endure under the Biden administration.
- N Engl J Med 2020; 383:2595-2598
For children, no other insurer has equaled Medicaid’s comprehensive coverage and cost-sharing protections. But Medicaid also has important limitations, and the imperative to achieve racial and socioeconomic health equity demands structural changes to the program.
- N Engl J Med 2020; 383:e115
The opinions of the late U.S. Supreme Court Justice Ruth Bader Ginsburg consistently emphasized values pertinent to the challenge to the Affordable Care Act that will be argued before the Court in November — particularly values of equality and common interests.
- N Engl J Med 2020; 383:e105
The authors analyze voters’ views on health care issues as represented in 19 national public opinion polls, including some as recent as October 2020. The contrasting opinions of Democratic and Republican voters and the implications of the 2020 election for the future of U.S. health policy are discussed.
- N Engl J Med 2020; 383:1601-1603
The political and economic instability wrought by Covid-19, frustrations with the Affordable Care Act’s limitations, and a polarized environment in which parties are willing to legislate without bipartisan support mean that major health policy change is possible.
- N Engl J Med 2020; 383:1503-1505
If the ACA remains in effect, any changes in a second Trump administration are likely to be modest and to represent a continuation of efforts begun during Trump’s first term. If the ACA is ruled unconstitutional, then far-reaching legislative changes will be required.